Skip to content

Author

K. Bendahhou

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical and Biological Predictors of Severe Palbociclib- Induced Neutropenia in Patients with Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Single-Center Study

Background: Palbociclib, a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, is a standard treatment for hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) metastatic breast cancer. However, severe neutropenia remains its most common dose-limiting toxicity. This study aimed to determi...

Latifa Doublali, Adnane Adnani, M. Bourhafour et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.